Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases

Journal of Neurology

Volumn 258, Issue 6, 2011, Pages 1034-1041

  Jesse, Sarah ^a   Brettschneider, Johannes ^a   Süssmuth, Sigurd D ^a   Landwehrmeyer, Bernhard G ^a   Von Arnim, Christine A F ^a   Ludolph, Albert C ^a   Tumani, Hayrettin ^a   Otto, Markus ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cerebrospinal fluid; CSF flow; Neurochemical investigation; Neurodegenerative disorders; Standard routine parameters

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[1-42]; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTIC ACID; OLIGOCLONAL BAND; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANALYTICAL PARAMETERS; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID LEVEL; CEREBROSPINAL FLUID TO SERUM RATIO; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MOTOR NEURON DISEASE; MULTIINFARCT DEMENTIA; NERVOUS SYSTEM PARAMETERS; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN SYNTHESIS; REFERENCE VALUE; RETROSPECTIVE STUDY; SPINOCEREBELLAR DEGENERATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS; LACTIC ACID; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; STATISTICS, NONPARAMETRIC;

EID: 79959856349     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5876-x     Document Type: Article

References (37)

1. N Andreasen C Hesse P Davidsson L Minthon A Wallin B Winblad H Vanderstichele E Vanmechelen K Blennow 1999 Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch Neurol 56 673 680 10.1001/archneur.56.6.673 1:STN:280:DyaK1M3psF2kuw%3D%3D 10369305 (Pubitemid 29266465)
2. S Apostolski, et al. 1991 Serum and CSF immunological findings in ALS Acta Neurol Scand 83 2 96 98 10.1111/j.1600-0404.1991.tb04656.x 1:STN:280:DyaK3M3gs1SjtA%3D%3D 2017904
3. J Brettschneider A Claus J Kassubek H Tumani 2005 Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases J Neurol 252 1067 1073 10.1007/s00415-005-0817-9 1:STN:280: DC%2BD2Mvpslynsw%3D%3D 15789126 (Pubitemid 41355837)
4. J Brettschneider H Tumani U Kiechle R Muche G Richards V Lehmensiek AC Ludolph M Otto 2009 IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome PLoS One 4 e7638 10.1371/journal.pone.0007638 19890384
5. Deutsche Gesellschaft für Psychiatrie PuN, Deutsche Gesellschaft für Neurologie (2009) S3-Leitlinie Demenzen. 038/013
6. DW Dickson C Bergeron SS Chin C Duyckaerts D Horoupian K Ikeda K Jellinger PL Lantos CF Lippa SS Mirra M Tabaton JP Vonsattel K Wakabayashi I Litvan 2002 Office of rare diseases neuropathologic criteria for corticobasal degeneration J Neuropathol Exp Neurol 61 935 946 1:STN:280: DC%2BD38nntVSkuw%3D%3D 12430710 (Pubitemid 35278715)
7. B Dubois D Burn C Goetz D Aarsland RG Brown GA Broe D Dickson C Duyckaerts J Cummings S Gauthier A Korczyn A Lees R Levy I Litvan Y Mizuno IG McKeith CW Olanow W Poewe C Sampaio E Tolosa M Emre 2007 Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force Mov Disord 22 2314 2324 10.1002/mds.21844 18098298 (Pubitemid 351155975)
8. L Frolich J Kornhuber R Ihl J Fritze K Maurer P Riederer 1991 Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG Eur Arch Psychiatry Clin Neurosci 240 363 366 10.1007/BF02279767 1:STN:280:DyaK3Mzks1Wqsg%3D%3D 1831668
9. A Fuchs R Rosenthal 1904 Physikalisch-chemische, zytologische und anderweitige Untersuchungen der Cerebrospinalflüssigkeit Wien Med Presse 45 2081 2087
10. S Gilman P Low N Quinn A Albanese Y Ben-Shlomo C Fowler H Kaufmann T Klockgether A Lang P Lantos I Litvan C Mathias E Oliver D Robertson I Schatz G Wenning 1998 Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology Clin Auton Res 8 359 362 10.1007/BF02309628 1:STN:280:DyaK1M%2FosV2jsg%3D%3D 9869555 (Pubitemid 29021108)
11. Hampel H F Müller-Spahn C Berger A Haberl M Ackenheil C Hock 1995 Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation Dementia 6 348 354
12. H Hampel HU Kotter F Padberg DA Korschenhausen HJ Moller 1999 Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis Alzheimer Dis Assoc Disord 13 9 19 10.1097/00002093- 199903000-00002 1:STN:280:DyaK1M3gs1ymtw%3D%3D 10192637 (Pubitemid 29176517)
13. HF Harbo J Finsterer J Baets C Van Broeckhoven S Di Donato B Fontaine P De Jonghe A Lossos T Lynch C Mariotti L Schols A Spinazzola Z Szolnoki SJ Tabrizi C Tallaksen M Zeviani JM Burgunder T Gasser 2009 EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias Eur J Neurol 16 777 785 10.1111/j.1468-1331.2009.02646.x 1:STN:280:DC%2BD1Mrhs1SjtA%3D%3D 19469830
14. JC Janssen AK Godbolt P Ioannidis EJ Thompson MN Rossor 2004 The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia J Neurol 251 184 188 10.1007/s00415-004-0296-4 1:STN:280:DC%2BD2c7gtV2gtQ%3D%3D 14991353 (Pubitemid 38221632)
15. G Keir RW Luxton L Thompson 1990 Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update Ann Clin Biochem 27 436 443 1:CAS:528:DyaK3MXktVGhtg%3D%3D 2281923 (Pubitemid 20340288)
16. T Klockgether 2005 Ataxias Diagnostic procedure and treatment Nervenarzt 76 1275 1283 10.1007/s00115-005-1992-8 1:STN:280:DC%2BD2MrjvFehsQ%3D%3D 16175415 quiz 1284-1275 (Pubitemid 41436256)
17. A Leonardi G Abbruzzese L Arata L Cocito M Vische 1984 Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis J Neurol 231 75 78 10.1007/BF00313720 1:STN:280:DyaL2c3ktFyqtg%3D%3D 6737012 (Pubitemid 14137306)
18. P Lewczuk H Esselmann M Bibl G Beck JM Maler M Otto J Kornhuber J Wiltfang 2004 Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature J Mol Neurosci 23 115 122 10.1385/JMN:23:1-2:115 1:CAS:528: DC%2BD2cXks12jtr8%3D 15126697 (Pubitemid 41359194)
19. I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin CG Goetz LI Golbe J Grafman JH Growdon M Hallett J Jankovic NP Quinn E Tolosa DS Zee 1996 Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1 9 1:STN:280:DyaK283ptFSjtA%3D%3D 8710059 (Pubitemid 26243849)
20. IG McKeith 2006 Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop J Alzheimers Dis 9 417 423 16914880 (Pubitemid 44253336)
21. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944 1:STN:280:DyaL2c3ks1altQ%3D%3D 6610841 (Pubitemid 14076461)
22. D Neary JS Snowden L Gustafson U Passant D Stuss S Black M Freedman A Kertesz PH Robert M Albert K Boone BL Miller J Cummings DF Benson 1998 Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1546 1554 1:STN:280:DyaK1M%2FntFWnsA%3D%3D 9855500
23. M Otto 2010 Dementia diagnostics 2.0-transfer from research studies into routine clinical practice Clin Chem 56 152 153 10.1373/clinchem.2009.136051 1:CAS:528:DC%2BC3cXhslaks7s%3D 19884484
24. H Reiber 1994 Flow rate of cerebrospinal fluid (CSF)- a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases J Neurol Sci 122 189 203 10.1016/0022-510X(94)90298-4 1:STN:280: DyaK2c3ptlSgtg%3D%3D 8021703 (Pubitemid 24097269)
25. H Reiber 1995 External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients Clin Chem 41 256 263 1:CAS:528:DyaK2MXktVGltbo%3D 7874779
26. H Reiber 2003 Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics Restor Neurol Neurosci 21 79 96 1:CAS:528:DC%2BD3sXns1Kgs7c%3D 14530572 (Pubitemid 37330250)
27. H Reiber JB Peter 2001 Cerebrospinal fluid analysis-disease-related data patterns and evaluation programs J Neurol Sci 184 101 122 10.1016/S0022-510X(00) 00501-3 1:CAS:528:DC%2BD3MXhs1CisL0%3D 11239944 (Pubitemid 32178265)
28. H Reiber S Ungefehr C Jacobi 1998 The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis Mult Scler 4 111 117 1:CAS:528:DyaK1cXlvVCgu7Y%3D 9762657 (Pubitemid 28410034)
29. H Reiber M Otto C Trendelenburg A Wormek 2001 Reporting cerebrospinal fluid data: knowledge base and interpretation software Clin Chem Lab Med 39 324 332 10.1515/CCLM.2001.051 1:CAS:528:DC%2BD3MXktFOltLk%3D 11388657 (Pubitemid 32433333)
30. I Skoog A Wallin P Fredman C Hesse O Aevarsson I Karlsson CG Gottfries K Blennow 1998 A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia Neurology 50 966 971 1:STN:280:DyaK1c3is1Sgsw%3D%3D 9566380 (Pubitemid 28212823)
31. SD Süssmuth 2008 Biochemical markers in CSF of ALS patients Curr Med Chem 15 1788 1801 10.2174/092986708785133031 18691039
32. The EFNS Task Force on Diagnosis, Management of Amyotrophic Lateral Sclerosis 2005 Guidelines for diagnosing and clinical care of patients and relatives Eur J Neurol 12 921 938 10.1111/j.1468-1331.2005.01351.x (Pubitemid 41823891)
33. H Tumani C Teunissen S Sussmuth M Otto AC Ludolph J Brettschneider 2008 Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases Expert Rev Mol Diagn 8 479 494 10.1586/14737159.8.4.479 1:CAS:528:DC%2BD1cXotFOqt7w%3D 18598229 (Pubitemid 351962092)
34. ML Upton RO Weller 1985 The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations J Neurosurg 63 867 875 10.3171/jns.1985.63.6.0867 1:STN:280:DyaL28%2Fjs1Clsw%3D%3D 4056901 (Pubitemid 16204522)
35. M Vandermeeren M Mercken E Vanmechelen J Six A van de Voorde JJ Martin P Cras 1993 Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J Neurochem 61 1828 1834 10.1111/j.1471-4159.1993.tb09823.x 1:CAS:528: DyaK2cXkvFCgtA%3D%3D 8228996 (Pubitemid 23317209)
36. G Waldemar B Dubois M Emre J Georges IG McKeith M Rossor P Scheltens P Tariska B Winblad 2007 Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline Eur J Neurol 14 e1 26 10.1111/j.1468-1331.2006.01605.x 1:STN:280: DC%2BD2s%2FisFSqsA%3D%3D 17222085 (Pubitemid 46088015)
37. Zimmermann R, Beck G, Knispel S, Maler JM, Weih M, Wiltfang J, Kornhuber J, Lewczuk P (2010) Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics. J Alzheimers Dis 19:1199-1203